Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
MedicalXpress
|
六月 29, 2026
Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗